Two cases of rapid onset Parkinson's syndrome following toxic ingestion of ethylene glycol and methanol

Clinical Pharmacology and Therapeutics

Volumn 81, Issue 1, 2007, Pages 114-121

  Reddy, N J ^a   Lewis, L D ^a   Gardner, T B ^a   Osterling, W ^b   Eskey, C J ^a   Nierenberg, D W ^a  

^a DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBIDOPA; ETHYLENE GLYCOL; LEVODOPA; METHANOL;

ADULT; ARTICLE; BASAL GANGLION; BREATHING MUSCLE; CASE REPORT; DISEASE ASSOCIATION; FEMALE; HUMAN; MALE; NEUROTOXICITY; PARKINSONISM; PRIORITY JOURNAL;

ACUTE DISEASE; ADULT; AGED; ANTIPARKINSON AGENTS; BASAL GANGLIA; CARBIDOPA; ETHYLENE GLYCOL; FEMALE; HUMANS; LEVODOPA; MALE; METHANOL; NECROSIS; PARKINSON DISEASE, SECONDARY; RESPIRATORY INSUFFICIENCY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33845979070     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/sj.clpt.6100013     Document Type: Article

References (28)

1. Watson, W.A. et al. 2004 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am. J. Emerg. Med. 23, 589-666 (2005).
2. Lewis, L.D., Smith, B.W. & Mamourian, A.C. Delayed sequelae after acute overdoses or poisonings: cranial neuropathy related to ethylene glycol ingestion. Clin. Pharm. Ther. 61, 692-699 (1997).
3. Morgan, B.W., Ford, M.D. & Follmer, R. Ethylene glycol ingestion resulting in brainstem and midbrain dysfunction. Clin. Toxicol. 38, 445-451 (2000).
4. Davis, D.P. et al. Ethylene glycol poisoning: case report of a record-high level and a review. J. Emerg. Med. 15, 653-667 (1997).
5. Walder, A.D. & Tyler, C.K.G. Ethylene glycol antifreeze poisoning. Anesthesia 49, 964-967 (1994).
6. Hanston, P., Vanbinst, R. & Mahieu, P. Determination of ethylene glycol tissue content after fatal oral poisoning and pathologic findings. Am. J. Foren. Med. Path. 23, 159-161 (2002).
7. Jacobsen, D. & McMartin, K. Ethylene glycol and other glycols. Methanol and formaldehyde poisoning. In Critical Care Toxicology: Diagnosis and Management of the Critically Poisoned Patient (eds. Bren, T.J., Wallace, K.L., Burkhart, K.K., Phillips, S.D., & Donovan, J.W.), 869-879 (Elsevier Mosby, Philadelphia, 2005).
8. Berman, L.B., Schreiner, G.E. & Feys, J. The nephrotoxic lesion of ethylene glycol. Ann. Intern. Med. 46, 611-619 (1957).
9. Jacobsen, D. et al. Poisoning with ethylene glycol and oxalic acid. Tidsskr Norske Laege. 101, 689-692 (1981).
10. Frommer, J.P. & Ayus, J.C. Acute ethylene glycol intoxication. Am. J. Nephrol. 2, 1-5 (1982).
11. Capo, M.A., Sevil, M.B. & Lopez, M.E. Ethylene glycol action and its cholinomimetic effects. J. Environ. Pathol. Toxicol. Oncol. 12, 155-159 (1993).
12. Mclean, D. et al. Methanol poisoning: a clinical and pathology study. Ann. Neurol. 8, 161-167 (1980).
13. Symon, L. et al. Physiological response to local areas of cerebral circulation in experimental primates determined by the method of hydrogen clearance. Stroke 4, 632-642 (1973).
14. Phang, P.T., Passerini, L., Mielke, B. & Berendt, R. Brain hemorrhage associated with methanol poisoning. Crit. Care Med. 16, 137-140 (1988).
15. Eells, J.T. et al. Therapeutic photobiomodulation for methanol-induced retinal toxicity. Proc. Natl. Acad. Sci. USA 10, 3439-3444 (2003).
16. Sharpe, J.A., Hostovsky, M. & Bilbao, J.M. Methanol optic neuropathy: histopathologic study. Neurology 32, 1093-1100 (1982).
17. McKellar, M.J., Hidajat, R.R. & Elder, M.J. Acute ocular methanol toxicity. Aust. NZ J. Ophthalmol. 25, 225-230 (1997).
18. Gaul, H.P., Wallace, C.J. & Roland, N. MRI findings in methanol intoxication. Am. J. Neurorad. 16, 1783-1786 (1995).
19. Haas, B., Trew, M. & Castle, P.C. Effects of respiratory muscle weakness on daily living function, quality of life, activity levels, and exercise capacity in mild to moderate Parkinson's disease. Am. J. Phys. Med. Rehab. 83, 601-607 (2004).
20. Obenour, W.H., Stevens, P.M., Cohen, A.A & McCutchen, J.J. The cause of abnormal pulmonary function in Parkinson's disease. Am. Rev. Resp. Dis. 105, 382-387 (1972).
21. Guggenheim, M.A., Couch, J.R. & Weinberg, W. Motor dysfunction as permanent complication of methanol ingestion. Arch. Neurol. 24, 550-554 (1971).
22. Schulman, G. & Himmelfarb, J. Hemodialysis, Brener & Rector's The Kidney 7th edn., (eds. Brenner B.M. & Rector Jr, F.C.) 2608-2614 (Saunders, an imprint of Elsevier 2004).
23. Landrigan, P.J. et al. Early environmental origins of neurodegenerative disease in later life. Environ. Health Persp. 113, 1230-1233 (2005).
24. Zhang, J. et al. Manganese ethylene-bis dithiocarbamate and selective dopaminergic neurodegeneration in rat: a link through mitochondrial dysfunction. J. Neurochem. 84, 336-346 (2003).
25. Hastings, T.G., Lewis, D.A. & Zigmond, M.J. Reactive dopamine metabolites and neurotoxicity: implications for Parkinson's disease. Adv. Exp. Med. Biol. 387, 97-106 (1996).
26. Chiueh, C.C. et al. In vivo generation of hydroxyl radicals and MPTP-induced dopaminergic toxicity in the basal ganglia. Ann. NY Acad. Sci. 738, 25-36 (1994).
27. Mayes, P.A. & Botham, K.M. In The Respiratory Chain & Oxidative phosphorylation, Harper's Illustrated Biochemistry 26th edn. (eds. Murray R.K., Granner D.K., Mayes P.A. & Rodwell V.W.) 92-101 (McGraw-Hill, New York, 2003).
28. Rudolf, A.C. Methanol. In Experimental and Clinical Neurotoxicity 2nd edn. (eds. Spencer P.S. & Schaumburg H.H. & Ludolph A.C.) 773-778 (Oxford University Press, Oxford, 2000).